31Aug 2023
High-Dose Dexamethasone's Role in Rescuing Severe COVID-19 Cases

High-Dose Dexamethasone's Role in Rescuing Severe COVID-19 Cases

A study analyzing 473 severe COVID-19 patients revealed varying impacts of high-dose (DXM20) and standard-dose (DXMSoC) dexamethasone. Bayesian analysis showcased a 29% chance of significant benefit and a 51.1% chance of harm. Notably, patients under 70 experienced an 86.5% chance of benefit from DXM20, while those on remdesivir had a 90.1% chance. Swift treatment initiation (within 7 days) also increased DXM20's effectiveness by 99.9%. High vs. low-dose dexamethasone in COVID-19 treatment remains an evolving topic.

  • #general medicine

Like

Save

Share